Laurent STORME

Prof. Laurent STORME


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Resuscitation
Verified
Journal Article
Closed access
CLCaroline Lefebvre
Caroline Lefebvre
TRThameur Rakza
Thameur Rakza
NWNathalie Weslinck
Nathalie Weslinck
PVPascal Vaast
Pascal Vaast
VHVéronique Houfflin-Debarge
Véronique Houfflin-Debarge
LSLaurent STORME
Laurent STORME

1 September 2018 in The Journal of Pediatrics
Verified
Journal Article
Closed access
DGDavid Guevorkian
David Guevorkian
SMSebastien Mur
Sebastien Mur
ECEric Cavatorta
Eric Cavatorta
LPLaurence Pognon
Laurence Pognon
TRThameur Rakza
Thameur Rakza
LSLaurent STORME
Laurent STORME

1 July 2018 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
PDF file
YZYing Zhong
Ying Zhong
DCDaniel Catheline
Daniel Catheline
AHAli Houeijeh
Ali Houeijeh
DSDyuti Sharma
Dyuti Sharma
LDLizhong Du
Lizhong Du
LSLaurent STORME
Laurent STORME
Pulmonary hypertension (PH) and right ventricular hypertrophy (RVH) affect 16–25% of premature infants with bronchopulmonary dysplasia (BPD), contributing significantly to perinatal morbidity and mortality. Omega-3 polyunsaturated fatty acids (PUFA ω-3) can improve vascular remodeling, angiogenesis, and inflammation under pathophysiological conditions. However, the effects of PUFA ω-3 supplementation in BPD-associated PH are unknown. The present study aimed to evaluate the effects of PUFA ω-3 on pulmonary vascular remodeling, angiogenesis, and inflammatory response in a hyperoxia-induced rat model of PH. From embryonic day 15, pregnant Sprague-Dawley rats were supplemented daily with PUFA ω-3, PUFA ω-6, or normal saline (0.2 ml/day). After birth, pups were pooled, assigned as 12 per litter, randomly assigned to either air or continuous oxygen exposure (fraction of inspired oxygen = 85%) for 20 days, and then euthanized for pulmonary hemodynamic and morphometric analysis. We found that PUFA ω-3 supplementation improved survival, decreased right ventricular systolic pressure and RVH caused by hyperoxia, and significantly improved alveolarization, vascular remodeling, and vascular density. PUFA ω-3 supplementation produced a higher level of total ω-3 in lung tissue and breast milk and was found to reverse the reduced levels of VEGFA, VEGF receptor 2, angiopoietin-1 (ANGPT1), endothelial TEK tyrosine kinase, endothelial nitric oxide synthase, and nitric oxide concentrations in lung tissue and the increased ANGPT2 levels in hyperoxia-exposed rats. The beneficial effects of PUFA ω-3 in improving lung injuries were also associated with an inhibition of leukocyte infiltration and reduced expression of the proinflammatory cytokines IL-1β, IL-6, and TNF-α. These data indicate that maternal PUFA ω-3 supplementation strategies could effectively protect against infant PH induced by hyperoxia.

Verified
Journal Article
Open access
PDF file
DSDyuti Sharma
Dyuti Sharma
ANArmande Subayi Nkembi
Armande Subayi Nkembi
EAEstelle Aubry
Estelle Aubry
AHAli HOUEIJEH
Ali HOUEIJEH
LBLaura Butruille
Laura Butruille
LSLaurent STORME
Laurent STORME
Bronchopulmonary dysplasia (BPD) is one of the most common complications of prematurity, occurring in 30% of very low birth weight infants. The benefits of dietary intake of polyunsaturated fatty acids ω-3 (PUFA ω-3) during pregnancy or the perinatal period have been reported. The aim of this study was to assess the effects of maternal PUFA ω-3 supplementation on lung injuries in newborn rats exposed to prolonged hyperoxia. Pregnant female Wistar rats (n = 14) were fed a control diet (n = 2), a PUFA ω-6 diet (n = 6), or a PUFA ω-3 diet (n = 6), starting with the 14th gestation day. At Day 1, female and newborn rats (10 per female) were exposed to hyperoxia (O2, n = 70) or to the ambient air (Air, n = 70). Six groups of newborns rats were obtained: PUFA ω-6/O2 (n = 30), PUFA ω-6/air (n = 30), PUFA ω-3/O2 (n = 30), PUFA ω-3/air (n = 30), control/O2 (n = 10), and control/air (n = 10). After 10 days, lungs were removed for analysis of alveolarization and pulmonary vascular development. Survival rate was 100%. Hyperoxia reduced alveolarization and increased pulmonary vascular wall thickness in both control (n = 20) and PUFA ω-6 groups (n = 60). Maternal PUFA ω-3 supplementation prevented the decrease in alveolarization caused by hyperoxia (n = 30) compared to PUFA ω-6/O2 (n = 30) or to the control/O2 (n = 10), but did not significantly increase the thickness of the lung vascular wall. Therefore, maternal PUFA ω-3 supplementation may protect newborn rats from lung injuries induced by hyperoxia. In clinical settings, maternal PUFA ω-3 supplementation during pregnancy and during lactation may prevent BPD development after premature birth.

1 November 2022 in Journal of Midwifery & Women's Health
Verified
Journal Article
Open access
BGBenjamin C. Guinhouya
Benjamin C. Guinhouya
MDMartine Duclos
Martine Duclos
CECarina Enea
Carina Enea
LSLaurent STORME
Laurent STORME
The objective of this work is to synthesize current knowledge about the effects of maternal physical activity during pregnancy on children's health. During the prenatal and postnatal periods, maternal physical activity has protective effects against the risks of macrosomia, obesity, and other associated cardiometabolic disorders. Even though longitudinal studies in humans are still necessary to validate them, these effects have been consistently observed in animal studies. A remarkable effect of maternal physical activity is its positive role on neurogenesis, language development, memory, and other cognitive functions related to learning.

7 February 2018 in Acta Paediatrica
Verified
Journal Article
Closed access
PDF file
LSLaurent STORME
Laurent STORME
JBJ Boubnova
J Boubnova
SMS Mur
S Mur
LPL Pognon
L Pognon
DSD Sharma
D Sharma
THThe French Reference Center For Rare Disease «Congenital Diaphragmatic Hernia»
The French Reference Center For Rare Disease «Congenital Diaphragmatic Hernia»